100 related articles for article (PubMed ID: 15778546)
61. Alterations of p14
López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C
Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733
[TBL] [Abstract][Full Text] [Related]
62. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
[TBL] [Abstract][Full Text] [Related]
63. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
64. Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer.
Verdoodt B; Sommerer F; Palisaar RJ; Noldus J; Vogt M; Nambiar S; Tannapfel A; Mirmohammadsadegh A; Neid M
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):295-301. PubMed ID: 21912429
[TBL] [Abstract][Full Text] [Related]
65. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
[TBL] [Abstract][Full Text] [Related]
66. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
67. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
68. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
69. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
[TBL] [Abstract][Full Text] [Related]
70. Cytomorphologic characteristics of next-generation sequencing-positive bile duct brushing specimens.
Rosenbaum MW; Arpin R; Limbocker J; Casey B; Le L; Dudley J; Iafrate AJ; Pitman MB
J Am Soc Cytopathol; 2020; 9(6):520-527. PubMed ID: 32839152
[TBL] [Abstract][Full Text] [Related]
71. Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi.
Papp T; Pemsel H; Rollwitz I; Schipper H; Weiss DG; Schiffmann D; Zimmermann R
J Med Genet; 2003 Feb; 40(2):E14. PubMed ID: 12566532
[No Abstract] [Full Text] [Related]
72. Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis.
Ishikawa A; Sasaki M; Sato Y; Ohira S; Chen MF; Huang SF; Oda K; Nimura Y; Nakanuma Y
Hum Pathol; 2004 Dec; 35(12):1505-14. PubMed ID: 15619210
[TBL] [Abstract][Full Text] [Related]
73. Adenovirus-mediated Ink4a/ARF gene transfer significantly suppressed the growth of pancreatic carcinoma cells.
Chen F; Li Y; Lu Z; Gao J; Chen J
Cancer Biol Ther; 2005 Dec; 4(12):1348-54. PubMed ID: 16258260
[TBL] [Abstract][Full Text] [Related]
74. Small cell carcinoma of the extrahepatic bile duct: case report and immunohistochemical analysis.
Kuraoka K; Taniyama K; Fujitaka T; Nakatsuka H; Nakayama H; Yasui W
Pathol Int; 2003 Dec; 53(12):887-91. PubMed ID: 14629756
[TBL] [Abstract][Full Text] [Related]
75. [Histopathological characteristics and coexpression of p53 and p16(INK4a) proteins in renal cancer].
Zivković S; Kostov M; Pavlović S; Mijović Z
Vojnosanit Pregl; 2008 Nov; 65(11):820-4. PubMed ID: 19069712
[TBL] [Abstract][Full Text] [Related]
76. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas.
Satoh K; Shimosegawa T; Moriizumi S; Koizumi M; Toyota T
Pancreas; 1996 May; 12(4):362-8. PubMed ID: 8740403
[TBL] [Abstract][Full Text] [Related]
77. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation.
Robertson LB; Armstrong GN; Olver BD; Lloyd AL; Shete S; Lau C; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Schildkraut J; Bernstein JL; Olson SH; Jenkins RB; Yang P; Rynearson AL; Wrensch M; McCoy L; Wienkce JK; McCarthy B; Davis F; Vick NA; Johansen C; Bødtcher H; Sadetzki S; Bruchim RB; Yechezkel GH; Andersson U; Melin BS; Bondy ML; Houlston RS
Fam Cancer; 2010 Sep; 9(3):413-21. PubMed ID: 20455025
[TBL] [Abstract][Full Text] [Related]
78. p53 mutagenesis in Klatskin tumors.
Jonas S; Springmeier G; Tauber R; Wiedenmann B; Lobeck H; Gessner R; Kreft B; Kling N; Moelling K; Neuhaus P
Hum Pathol; 1998 Sep; 29(9):955-60. PubMed ID: 9744311
[TBL] [Abstract][Full Text] [Related]
79. Transcriptional specificity in various p53-mutant cells.
Okaichi K; Izumi N; Takamura Y; Fukui S; Kudo T
Anticancer Res; 2013 Mar; 33(3):923-8. PubMed ID: 23482763
[TBL] [Abstract][Full Text] [Related]
80. Association of Micronuclear Frequency with Dysplasia and Cytogenetic Changes (p53 Mutation and p16 Expression) in Oral Potentially Malignant Disorders.
Tammewar S; Gadkari R
J Cytol; 2022; 39(2):53-58. PubMed ID: 35814878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
